Pneumonia in a patient with familial Mediterranean fever successfully treated with anakinra-case report and review

Rheumatology International

Volumn 32, Issue 6, 2012, Pages 1801-1804

  Hennig, Stefanie ^a   Bayegan, Keywan ^a   Uffmann, Martin ^a   Thalhammer, Florian ^a   Winkler, Stefan ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anakinra; Familial mediterranean fever; IL 1 receptor antagonist; Pneumonia

Indexed keywords

C REACTIVE PROTEIN; COLCHICINE; LINEZOLID; MEROPENEM; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SERUM AMYLOID A; TEICOPLANIN;

ADULT; AMYLOIDOSIS; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; ECHOCARDIOGRAPHY; FAMILIAL MEDITERRANEAN FEVER; HISTOPATHOLOGY; HUMAN; INJECTION SITE DISCOMFORT; LONG TERM CARE; MALE; MEDIASTINOSCOPY; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SYMPTOM; THORAX RADIOGRAPHY; TREATMENT FAILURE; TREATMENT RESPONSE;

ADULT; AMYLOIDOSIS; ANTI-INFECTIVE AGENTS; COLCHICINE; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FAMILIAL MEDITERRANEAN FEVER; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; KIDNEY TRANSPLANTATION; MALE; PNEUMONIA; RECURRENCE; TREATMENT OUTCOME;

EID: 84863874705     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1429-y     Document Type: Review

References (15)

1. Lachmann HJ, Sengul B, Yavuzsen TU (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology 45:746-750
2. Onen F (2006) Familial Mediterranean fever. Rheumatol Int 26:489-496
3. The International FMF Consortium (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90:797-807
4. The French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat General 17:25-31
5. Livneh A, Langevitz P (2000) Diagnostic and treatment concerns in familial Mediterranean fever. Baillieres Best Pract Res Clin Rheumatol 14:477-498
6. Chae JJ, Wood G, Richard K, Jaffe H, Colburn NT, Masters SL, Gumucio DL, Shoham NG, Kastner DL (2008) The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kB through ist N-terminal fragment. Blood 112:1794-1803
7. Ilfeld DN, Mazar A, Garty M, Fink G, Spitzer S, Pecht M, Netzer L, Trainin N, Kuperman O (1986) Effect of oral colchicine on T cell subsets, monocytes and concanavalin A-induced suppressor cell function in asthmatic patients. Clin Allergy 16:407-416
8. Chae JJ, Wood G, Masters SL, Richard K, Park G, Smith BJ, Kastner DL (2006) The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci USA 103:9982-9987
9. Kineret-(anakinra) (2008) Prescribing information, medical information connection US, 2008 Amgen
10. Bresnihan B (2001) The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis. Semin Arthritis Rheum 30:17-20
11. Roldan R, Ruiz AM, Miranda MD, Collantes E (2008) Anakinra: new therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine. Joint Bone Spine 75:504-505
12. Kuijk LM, Govers AM, Frenkel J, Hofhuis WJ (2007) Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra. Ann Rheum Dis 66:1545
13. Calligaris L, Marchetti F, Tommasini A, Ventura A (2008) The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever. Eur J Pediatr 167:695-696
14. Gattringer R, Lagler H, Gattringer KB, Knapp S, Burgmann H, Winkler S, Graninger W, Thalhammer F (2007) Anakinra in two adolescent female patients suffering from colchicine-resistant familial Mediterranean fever: effective but risky. Eur J Clin Invest 37:912-914
15. Moser C, Pohl G, Haslinger I, Knapp S, Rowczenio D, Russel T, Lachmann HJ, Lang U, Kovarik J (2009) Successful treatment of Familial Mediterranean fever with Anakinra and outcome after renal transplantation. Nephrol Dial Transplant 24:676-678